Leadership in the Pharmaceutical Industry
ABRE is built by leaders who understand both the fragility of the global pharmaceutical supply chain and the complexity of addressing it. Our team, comprising former members of U.S. Congress, national security advisors, doctors, and advanced technologists, has extensive experience in building AI, simulation, and defense platforms. We have worked at the intersection of crisis response, critical infrastructure, and global policy, focusing on biothreat preparedness. Now, we are developing the foresight system we wish had existed during the last global disruption.
Leadership
Founder Former U.S. Congressman | National Security & Health Policy Leader | Doctor of Veterinary Medicine
Dr. Ted Yoho is a Doctor of Veterinary Medicine with more than 30 years of clinical practice and extensive experience at the intersection of medicine, national security, and public policy.
From 2013 to 2021, he served in the U.S. House of Representatives, including on the House Agriculture Committee and the House Foreign Affairs Committee, where he chaired the Asia Pacific Subcommittee. His congressional work focused heavily on supply-chain security, biothreat preparedness, global health, and reducing U.S. dependence on foreign pharmaceutical manufacturing.
Following Congress, Dr. Yoho has served as a senior policy advisor in Washington, D.C., helping shape strategies related to food security, pharmaceutical resilience, and biological risk. He has been a consistent advocate for restoring domestic API manufacturing capacity and strengthening U.S. readiness against biological, geopolitical, and supply-chain disruptions.
At ABRE, Dr. Yoho leads policy and national-security strategy, guiding efforts to advance pharmaceutical sovereignty and next-generation biodefense and supply-chain resilience capabilities.
Founder & Executive Leader | Operations, Technology, and Government Programs
Andy Chance is a former Fortune 500 Vice President with extensive experience leading large-scale, regulated operations across healthcare, technology, and government-adjacent environments.
His career includes building and operating technology-driven organizations that function within complex regulatory frameworks, engaging directly with senior stakeholders across federal agencies, congressional offices, and defense-aligned institutions. Andy brings deep familiarity with government procurement, multi-agency coordination, and executing programs where reliability, compliance, and continuity are mission-critical.
As Co-Founder and executive leader of ABRE, Andy is responsible for translating national-security needs into executable systems. His focus is on developing a decision and coordination platform that strengthens biological resilience, protects supply-chain continuity, and supports operational readiness across critical health and security domains.
Chief Technology Lead | AI & Mission-Critical Systems
Karel Becerra is a senior technology leader with more than 20 years of experience designing, building, and operating enterprise-scale, mission-critical software systems in regulated and high-consequence environments.
He specializes in taking advanced artificial intelligence research from concept to production, with hands-on experience across machine learning, deep learning, and computer vision. His work includes direct collaboration with academic and scientific teams on peer-reviewed research, as well as the deployment of secure, resilient systems built for scale, reliability, and integration.
At ABRE, Karel leads development of the platform’s predictive analytics and decision-support capabilities, ensuring the system meets the performance, security, and operational rigor required for defense and biodefense missions.
Dr. Paul Fredricks
SR Advisor, Major General (Ret.)
Former White House Advisor
Dr. Paul Friedrichs is a former White House biodefense leader and retired U.S. Air Force Major General who advised the President on pandemic preparedness and biological threats. He supports USAPI Pharma’s national security strategy and pharmaceutical supply chain resilience initiatives.
Jason Yoho
Chief Revenue Officer, Infrastructure Growth & Federal Market Development
Jason is a technology business leader and strategic advisor with experience scaling enterprise infrastructure, cybersecurity, AI, and public-sector growth initiatives. He previously helped lead transformation within Lumen’s $1.8B Public Sector segment and has raised more than $80M in venture capital across his career. His background includes cloud infrastructure, national cyber policy, supply chain security, and strategic market development. At ABRE, Jason supports growth strategy, federal opportunity development, investor positioning, and commercialization of ABRE’s biosecurity intelligence infrastructure platform.
Ken Staley
Biodefense Strategist | Former White House Advisor
Ken Staley is a biodefense and global health security leader with senior roles at Palantir, the White House National Security Council, State Department, and USAID. He supports USAPI Pharma on national security strategy and pharmaceutical supply chain resilience.
Jackson Streeter MD
SR. Advisor U.S. Navy Flight Surgeon (Ret.)
Former U.S. Navy Flight Surgeon and TopGun instructor, Dr. Streeter is a life sciences and medical technology executive advising ABRE on biothreat readiness, medical innovation, and strategic partnerships. He has founded multiple medical technology companies, including PhotoThera and American Veterinary Laser, with several successful exits. : QTRX).
Larry Burgess
SR Advisor Organic Chemist
Pharmaceutical executive and drug discovery leader who has founded and successfully exited multiple pharmaceutical startups. He brings deep experience in drug development and commercialization strategy across the biotech sector. He supports USAPI Pharma’s work in API and KSM supply chain tracking, reshoring, and resilience.